Down-regulated HSA_circ_0003528 inhibits hepatocellular carcinoma aggressiveness via the miR-212-3p/XIAP axis

References

• Sim H-W, Knox J. Hepatocellular carcinoma in the era of immunotherapy. Curr Probl Cancer. 2018;42(1):40–48.
   PubMed Web of Science ®Google Scholar
• Feng Y, Yang Y, Zhao X, et al. Circular RNA circ0005276 promotes the proliferation and migration of prostate cancer cells by interacting with FUS to transcriptionally activate XIAP. Cell Death Dis. 2019;10(11):792.
   PubMed Web of Science ®Google Scholar
• Forner A, Reig M, Bruix J, et al. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301–1314.
   PubMed Web of Science ®Google Scholar
• Yoon SM, Ryoo B-Y, Lee SJ, et al. Efficacy and safety of transarterial chemoembolization plus external beam Radiotherapy vs Sorafenib in Hepatocellular carcinoma with Macroscopic vascular invasion: a randomized clinical trial. JAMA Oncol. 2018;4(5):661–669.
   PubMed Web of Science ®Google Scholar
• Chang Y, Jeong SW, Young Jang J, et al. Recent updates of transarterial Chemoembolilzation in Hepatocellular Carcinoma. Int J Mol Sci. 2020;21(21):8165.
   PubMed Web of Science ®Google Scholar
• Chen JQ, Ou YL, Huang Z-P, et al. MicroRNA-212-3p inhibits the Proliferation and invasion of human Hepatocellular Carcinoma cells by suppressing CTGF expression. Sci Rep. 2019;9(1):9820.
   PubMed Web of Science ®Google Scholar
• Han K, Kim JH. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system. World J Gastroenterol. 2015;21(36):10327–10335.
   PubMed Web of Science ®Google Scholar
• Liu Z, Yu Y, Huang Z, et al. CircRNA-5692 inhibits the progression of hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP expression. Cell Death Dis. 2019;10(12):900.
   PubMed Web of Science ®Google Scholar
• Patop IL, Wust S, Kadener S, et al. Past, present, and future of circ RNA s. EMBO J. 2019;38(16):e100836.
   PubMed Web of Science ®Google Scholar
• Wang L, Long H, Zheng Q, et al. Circular RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression. Mol Cancer. 2019;18(1):119.
   PubMed Web of Science ®Google Scholar
• Shen H, Li H, Zhou J, et al. Circular RNA HSA_circ_0032683 inhibits the progression of hepatocellular carcinoma by sponging microRNA-338-5p. Bioengineered. 2022;13(2):2321–2335.
   PubMed Web of Science ®Google Scholar
• Yu J, Xu Q-G, Wang Z-G, et al. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma. J Hepatol. 2018;68(6):1214–1227.
   PubMed Web of Science ®Google Scholar
• Yu T, Wang Y, Fan Y, et al. CircRNAs in cancer metabolism: a review. J Hematol Oncol. 2019;12(1):90.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wang W, Zhou Q, et al. Roles of circRNAs in the tumour microenvironment. Mol Cancer. 2020;19(1):14.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li J, Cui Q, et al. Circular RNA HSA_circ_0006091 as a novel biomarker for hepatocellular carcinoma. Bioengineered. 2022;13(2):1988–2003.
   PubMed Web of Science ®Google Scholar
• Huang X-Y, Zhang P-F, Wei C-Y, et al. Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis. Mol Cancer. 2020;19(1):92.
   PubMed Web of Science ®Google Scholar
• Wang M, Yang Y, Yang J, et al. circ_KIAA1429 accelerates hepatocellular carcinoma advancement through the mechanism of m6A-YTHDF3-Zeb1. Life Sci. 2020;257:118082.
   PubMed Web of Science ®Google Scholar
• Liang L, Zhang L, Zhang J, et al. <p>Identification of circRNA-miRNA-mRNA networks for exploring the fundamental mechanism in lung Adenocarcinoma. Onco Targets Ther. 2020;13:2945–2955.
   PubMed Web of Science ®Google Scholar
• Ding SF, Habib NA, Dooley J, et al. Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis. Br J Cancer. 1991;64(6):1083–1087.
   PubMed Web of Science ®Google Scholar
• Wang F, Xu X, Zhang N, et al. Identification and integrated analysis of hepatocellular carcinoma-related circular RNA signature. Ann Transl Med. 2020;8(6):294.
   PubMed Web of Science ®Google Scholar
• Huang X-Y, Huang Z-L, Huang J, et al. Exosomal circRNA-100338 promotes hepatocellular carcinoma metastasis via enhancing invasiveness and angiogenesis. J Exp Clin Cancer Res. 2020;39(1):20.
   PubMed Web of Science ®Google Scholar
• Huang Z, Yao F, Liu J, et al. Up-regulation of circRNA-0003528 promotes mycobacterium tuberculosis associated macrophage polarization via down-regulating miR-224-5p, miR-324-5p and miR-488-5p and up-regulating CTLA4. Aging (Albany NY). 2020;12(24):25658–25672.
   PubMedGoogle Scholar
• Zhang B, Li F, Zhu Z, et al. CircRNA CDR1as/miR-1287/Raf1 axis modulates Hepatocellular Carcinoma progression through MEK/ERK Pathway. Cancer Manag Res. 2020;12:8951–8964.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang Y, Wang S, et al. MiR-212-3p suppresses high-grade serous ovarian cancer progression by directly targeting MAP3K3. Am J Transl Res. 2020;12(3):875–888.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Cheng S, Cao L, Yang J, Wang J, Chen Y, et al. LINC00978 promotes hepatocellular carcinoma carcinogenesis partly via activating the MAPK/ERK pathway. Biosci Rep. 2020;40:3.
   Web of Science ®Google Scholar
• Chen CH, Su YJ, Ding H, et al. Circular RNA ZNF292 affects proliferation and apoptosis of hepatocellular carcinoma cells by regulating Wnt/beta-catenin pathway. Eur Rev Med Pharmacol Sci. 2020;24(23):12124–12130.
   PubMed Web of Science ®Google Scholar
• Cai Y, Jia Y. Circular RNA SOX5 promotes the proliferation and inhibits the apoptosis of the hepatocellular carcinoma cells by targeting miR-502-5p/synoviolin 1 axis. Bioengineered. 2022;13(2):3362–3370.
   PubMed Web of Science ®Google Scholar
• Conn SJ, Pillman KA, Toubia J, et al. The RNA binding protein quaking regulates formation of circRNAs. Cell. 2015;160(6):1125–1134.
   PubMed Web of Science ®Google Scholar
• Xu J, Ji L, Liang Y, et al. CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1. Signal Transduct Target Ther. 2020;5(1):298.
   PubMed Web of Science ®Google Scholar
• Huang X-Y, Huang Z-L, Zhang P-B, et al. CircRNA-100338 is associated with mTOR signaling pathway and poor prognosis in Hepatocellular Carcinoma. Front Oncol. 2019;9:392.
   PubMed Web of Science ®Google Scholar
• Li X, Zou -Z-Z, Wen M, et al. ZLM-7 inhibits the occurrence and angiogenesis of breast cancer through miR-212-3p/Sp1/VEGFA signal axis. Mol Med. 2020;26(1):109.
   PubMed Web of Science ®Google Scholar
• Xu J, Wan Z, Tang M, et al. N6-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating β-catenin signaling. Mol Cancer. 2020;19(1):163.
   PubMed Web of Science ®Google Scholar
• Chen W, Song J, Bian H, et al. The functions and targets of miR-212 as a potential biomarker of cancer diagnosis and therapy. J Cell Mol Med. 2020;24(4):2392–2401.
   PubMed Web of Science ®Google Scholar
• Wanet A, Tacheny A, Arnould T, et al. miR-212/132 expression and functions: within and beyond the neuronal compartment. Nucleic Acids Res. 2012;40(11):4742–4753.
   PubMed Web of Science ®Google Scholar
• Yuan Z, Ye M, Qie J, et al. FOXA1 promotes cell proliferation and suppresses apoptosis in HCC by directly regulating miR-212-3p/FOXA1/AGR2 signaling pathway. Onco Targets Ther. 2020;13:5231–5240.
   PubMed Web of Science ®Google Scholar
• Tu H, Costa M. XIAP’s profile in human cancer. Biomolecules. 2020;10(11):1493.
   PubMed Web of Science ®Google Scholar
• Abbas R, Larisch S. Targeting XIAP for promoting cancer cell death-the story of ARTS and SMAC. Cells. 2020;9(3):3.
   Web of Science ®Google Scholar
• Jeong S, Jo MJ, Yun HK, et al. Cannabidiol promotes apoptosis via regulation of XIAP/Smac in gastric cancer. Cell Death Dis. 2019;10(11):846.
   PubMed Web of Science ®Google Scholar
• Yang Z, Chen G, Cui Y, et al. The safety and efficacy of TACE combined with apatinib on patients with advanced hepatocellular carcinoma: a retrospective study. Cancer Biol Ther. 2019;20(3):321–327.
   PubMed Web of Science ®Google Scholar
• Seo HG, Kim HB, Yoon JY, et al. Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. Cell Death Dis. 2020;11(9):815.
   PubMed Web of Science ®Google Scholar
• Zhou H-Z, Zeng H-Q, Yuan D, et al. NQO1 potentiates apoptosis evasion and upregulates XIAP via inhibiting proteasome-mediated degradation SIRT6 in hepatocellular carcinoma. Cell Commun Signal. 2019;17(1):168.
   PubMed Web of Science ®Google Scholar